DiogenX

Viacyte

This regenerative medicine company develops stem cell-derived islet replacement therapies for patients living with type 1 diabetes.

Zucara Therapeutics

This company develops a drug therapy to prevent hypoglycemia in patients with type 1 diabetes using insulin therapy.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.

Endogenex

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

Enthera Pharmaceuticals

This biotech company develops monoclonal antibodies and fusion proteins for patients with autoimmune conditions including type 1 diabetes and inflammatory bowel disease.

Encellin

The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.

Zag Bio

This biotechnology company develops thymus-targeted bifunctional antibodies that deliver antigens to induce immune tolerance in patients with autoimmune diseases such as type 1 diabetes.